BNP PARIBAS ASSET MANAGEMENT Holding S.A.
Position in RCUS — Arcus Biosciences, Inc.
CIK 1520354
Paris, I0
Position in RCUS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$43,764,201
+$8,021,516 QoQ
Shares Held
1,419,533
-14.2% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#17
of 230 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. RCUS ranks #18 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
897,893 | $446,010,389 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
331,560 | $206,740,921 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
799,297 | $192,606,596 | |
| 4 | ARGX |
Argenx SE
|
121,786 | $112,989,396 | |
| 5 | INCY |
Incyte Corp
|
937,763 | $106,304,813 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
1,290,731 | $77,908,522 | |
| 7 | VCEL |
Vericel Corp
|
1,639,988 | $72,963,065 | |
| 8 | CYTK |
Cytokinetics Inc
|
827,810 | $70,521,132 |
All Filings in RCUS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,764,201 | 1,419,533 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $35,742,685 | 1,654,754 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $40,210,121 | 1,687,374 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $19,311,795 | 1,419,985 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $11,361,208 | 1,395,726 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $12,779,949 | 1,628,019 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $22,659,363 | 1,521,784 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $14,235,723 | 931,048 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $11,335,658 | 744,298 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $12,933,272 | 685,025 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $10,308,785 | 539,727 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $9,277,708 | 516,864 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,412,903 | 611,172 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $14,132,206 | 774,792 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $15,831,574 | 765,550 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $16,286,274 | 622,564 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $14,154,974 | 558,602 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $25,156,191 | 797,091 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $34,856,568 | 861,294 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $27,376,646 | 785,106 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $8,561,918 | 311,796 | Shares | Defined | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||